2016
DOI: 10.1186/s40959-016-0016-0
|View full text |Cite
|
Sign up to set email alerts
|

Juvenile competitive triathlete after cardiotoxic anthracycline therapy for Acute Myeloid Leukemia

Abstract: Objective: The treatment of Acute Myeloid Leukemia (AML) leads to several functional limitations. Especially cardiac burden following cardiotoxic chemotherapy, which limits exercise and competitive sport in the long-term survivors. Subject and methods: We report on a young female amateur triathlete born in 1997, who was diagnosed with AML at the age of fifteen. She had chemotherapy with a cumulative dose of about 1000 mg/m 2 anthracyclines and allogeneic stem cell transplantation which was successful, but she … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 24 publications
(25 reference statements)
0
0
0
Order By: Relevance